WASHINGTON — The U.S. House of Representatives has given initial approval to a proposal to establish an FDA office in the countries signatory to the historic Abraham Accords. The initiative is part of a watershed plan to further strengthen regional ties and reduce America’s dependence on Chinese pharmaceutical supplies.
The bipartisan bill, which has been on the drawing board over the last year, amended a direct reference to Israel and referred to a bureau in the “Abraham Accord region” amid ongoing vacillation by the Israeli Health Ministry regarding whether to sign on with the project.
